|
|
List of Resources about hyaluronic
acid: 1. Marshall KW.
Viscosupplementation for osteoarthritis: current status, unresolved
issues and future directions. J Rheumatol 1998;25:2056-8.
2. George E. Intra-articular hyaluronan treatment for osteoarthritis.
Ann Rheum Dis 1998;57:637-40.
3. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, et al.
The role of elastoviscosity in the efficacy of viscosupplementation for
osteoarthritis of the knee: a comparison of hylan G-F 20 and a
lower-molecular-weight hyaluronan. Clin Ther 1999;21:1549-62.
4. Cohen MD. Hyaluronic acid treatment (viscosupplementation) for OA of
the knee. Bull Rheum Dis 1998;47:4-7.
5. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the
treatment of osteoarthritis. J Rheumatol 1993;20(suppl 39):3-9.
6. Weiss C, Balazs EA, St. Onge R, Denlinger JL. Clinical studies of the
intraarticular injection of HealonR (sodium hyaluronate) in the
treatment of osteoarthritis of human knees. Osteoarthritis symposium.
Palm Aire, Fla., October 20-22, 1980. Semin Arthritis Rheum.
1981;11(suppl 1):143-4.
7. Peyron JG. Intraarticular hyaluronan injections in the treatment of
osteoarthritis: state-of-the-art review. J Rheumatol
1993;39(suppl):10-5.
8. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular
injections of 750 kD hyaluronan in the treatment of osteoarthritis: a
randomised single centre double-blind placebo-controlled trial of 91
patients demonstrating lack of efficacy. Ann Rheum Dis 1994;53:529-34.
9. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson
K, et al. Intra-articular hyaluronan injections in the treatment of
osteoarthritis of the knee: a randomised, double blind, placebo
controlled multicentre trial. Hyaluronan Mulicentre Trial Group. Ann
Rheum Dis 1996;55:424-31.
10. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight
sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year
placebo-controlled trial. Osteoarthritis Cart 1993;1:97-103.
11. Marshall KW. Viscosupplementation for osteoarthritis: current
status, unresolved issues and future directions. J Rheumatol
1998;25:2056-8.
12. Listrat V, Ayral X, Paternello F, Bonvarlet JP, Simonnet J, Amor B,
et al. Arthroscopic evaluation of potential structure modifying activity
of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis
Cart 1997;5:153-60.
13. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan)
in the treatment of patients with osteoarthritis of the knee: a
randomized clinical trial. J Rheumatol 1998;25:2203-12 [Published
erratum appears in J Rheumatol 1999;26:1216].
14. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with
hylan G-F 20: a 26-week controlled trial of efficacy and safety in the
osteoarthritic knee. Clin Ther 1998;20:410-23.
15. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade
JP, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc)
in the treatment of osteoarthritis of the knee: a Canadian multicenter
trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal
anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cart
1995;3:213-25.
16. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De
Medicis R. Viscosupplementation with hylan for the treatment of
osteoarthritis: findings from clinical practice in Canada. J Rheumatol
1996;23:1579-85.
17. Disla E, Infante R, Fahmy A, Karten I, Cuppari GG. Recurrent acute
calcium pyrophosphate dihydrate arthritis following intraarticular
hyaluronate injection. Arthritis Rheum 1999;42:1302-3.
18. Maheu E. Hyaluronan in knee osteoarthritis: a review of the clinical
trials with hyalgan. Eur J Rheumatol Inflamm 1995;15:17-24.
|
